Selected Lessons Learned from the Dialysis Outcomes and Practice Patterns Study (DOPPS)

2005 ◽  
pp. 58-68 ◽  
Author(s):  
Ronald L. Pisoni ◽  
Roger N. Greenwood
Keyword(s):  
Practice Patterns ◽  
Lessons Learned ◽  
Dialysis Outcomes

scholarly journals The Dialysis Outcomes and Practice Patterns Study (DOPPS) Practice Monitor: Rationale and Methods for an Initiative to Monitor the New US Bundled Dialysis Payment System

2011 ◽  
Vol 57 (6) ◽  
pp. 822-831 ◽  
Author(s):  
Bruce Robinson ◽  
Douglas Fuller ◽  
Dawn Zinsser ◽  
Justin Albert ◽  
Brenda Gillespie ◽  
...  
Keyword(s):  
Practice Patterns ◽  
Payment System ◽  
Dialysis Outcomes

MO792CONTEMPORARY MINERAL AND BONE DISORDER MARKERS AND TREATMENT AMONG HEMODIALYSIS PATIENTS IN THE EUROPEAN DIALYSIS OUTCOMES AND PRACTICE PATTERNS STUDY (DOPPS)*

2021 ◽  
Vol 36 (Supplement_1) ◽  
Author(s):  
Brian Bieber ◽  
Indranil Dasgupta ◽  
Pieter Evenepoel ◽  
Stefan H Jacobson ◽  
Piergiorgio Messa ◽  
...  
Keyword(s):  
Vitamin D ◽  
Practice Patterns ◽  
Hemodialysis Patients ◽  
Serum Phosphorus ◽  
Active Vitamin ◽  
Mineral And Bone Disorder ◽  
Bone Disorder ◽  
Country Differences ◽  
Dialysis Outcomes ◽  
The Uk

Abstract Background and Aims Chronic kidney disease mineral and bone disorder (CKD-MBD) is characterized by abnormalities in serum calcium, phosphorus, and parathyroid hormone (PTH) and associated with morbidity and mortality. Previous publications from the Dialysis Outcomes and Practice Patterns Study (DOPPS) have demonstrated country differences in the prevalence and treatment of CKD-MBD among hemodialysis patients in participating European countries. We aim to compare the distribution of CKD-MBD related labs and treatments across countries in a contemporary population of European hemodialysis patients. Method DOPPS is an international prospective cohort study of hemodialysis patients ≥18 years of age. Patients are enrolled randomly from a representative sample of dialysis facilities within each nation at the start of each study phase. The current analysis includes n=1,701 patients from 91 facilities in the initial prevalent cross section of Europe DOPPS phase 7 (2019-present; Belgium, Germany, Italy, Spain, Sweden, UK). Results from Belgium should be considered preliminary as initial questionnaire completion is ongoing. Results The % of patients with a high PTH (>600 pg/mL) ranged from 6% in Italy to 24% in the UK, with 12-17% having high PTH in all other countries. Mean serum total calcium ranged from 8.7 in Germany to 9.1 mg/dL in the UK (Table). Mean serum phosphorus varied from 4.5 in Belgium to 5.3 mg/dL in Germany. Dialysate calcium of 2.5 mEq/L was predominant in Germany, Sweden, and the UK while 3.0 mEq/L was the most common prescription in Belgium, Italy, and Spain. Calcimimetic prescription ranged from 13% in the UK to 32% in Spain. Etelcalcetide prescription ranged from 1% in the UK to 12% in Spain and 14% in Italy. Active vitamin D prescription ranged from 27% in Belgium to 75% in Sweden. Nearly all vitamin D prescriptions were administered intravenously in Spain versus about half in Italy; in all other countries, the route of active vitamin D administration was primarily oral. Patient age and dialysis vintage varied by country, potentially contributing to some of the observed country differences in MBD marker levels and treatment practices. Conclusion CKD-MBD related abnormalities in PTH, serum phosphorus and calcium remain common in European dialysis patients, with prevalence varying considerably by country. Substantial international variation in CKD-MBD treatments was also observed in prescription of vitamin D and calcimimetics. Uptake of the relatively new calcimimetic, etelcalcetide, varied considerably by country. A detailed understanding of the effect of treatment variation on CKD-MBD marker levels and patient outcomes is needed to provide important insights for the European HD community in optimizing management of secondary hyperparathyroidism.

scholarly journals Data from the Dialysis Outcomes and Practice Patterns Study validate an association between high intravenous iron doses and mortality

2015 ◽  
Vol 87 (1) ◽  
pp. 162-168 ◽  
Author(s):  
George R. Bailie ◽  
Maria Larkina ◽  
David A. Goodkin ◽  
Yun Li ◽  
Ronald L. Pisoni ◽  
...  
Keyword(s):  
Practice Patterns ◽  
Intravenous Iron ◽  
Dialysis Outcomes

scholarly journals Hemodialysis vascular access preferences and outcomes in the Dialysis Outcomes and Practice Patterns Study (DOPPS)

2002 ◽  
Vol 61 (6) ◽  
pp. 2266-2271 ◽  
Author(s):  
Eric W. Young ◽  
Dawn M. Dykstra ◽  
David A. Goodkin ◽  
Donna L. Mapes ◽  
Robert A. Wolfe ◽  
...  
Keyword(s):  
Vascular Access ◽  
Practice Patterns ◽  
Hemodialysis Vascular Access ◽  
Dialysis Outcomes

scholarly journals Often forgotten, transport modality to dialysis may be life-saving

2020 ◽  
Vol 13 (4) ◽  
pp. 510-512
Author(s):  
Raul Fernandez-Prado ◽  
Emilio Gonzalez-Parra ◽  
Alberto Ortiz
Keyword(s):  
Disease Transmission ◽  
Elderly Care ◽  
Well Being ◽  
Lessons Learned ◽  
Care Plan ◽  
Insurance Companies ◽  
Source Of Infection ◽  
Dialysis Facility ◽  
Related Quality ◽  
Dialysis Outcomes

Abstract Haemodialysis patients commute to the dialysis facility thrice weekly, for a total of six trips per week. While nephrologists may think that how patients do this is up to them and their insurance companies, there is growing evidence that providing advice on how to commute to dialysis is part of an integrated care plan for dialysis patients. In this issue of Clinical Kidney Journal, two reports emphasize the importance of transport modality on dialysis patient well-being and even survival. Rincon et al. report on the epidemiology and clinical spectrum of coronavirus disease 2019 (COVID-19) in a Spanish haemodialysis unit. A key source of infection was related to access to healthcare or elderly care facilities. Indeed, healthcare transportation with future symptomatic [odds ratio (OR) = 3.33] or asymptomatic (OR = 4.73) COVID-19 patients increased the risk of infection. Working with transport providers to minimize cross-infection between patients during transport was one of the measures taken to stop disease transmission. Lessons learned from COVID-19 may also apply to influenza and other infections. In the second report, Yazawa et al. describe an association between transport modality to the dialysis facility and health-related quality of life (QOL) among haemodialysis patients in the Japanese Dialysis Outcomes and Practice Patterns study. These reports emphasize the need for nephrologists to understand how patients are transported to dialysis and how transport modality may be optimized to promote QOL and decrease potentially life-threatening complications.

scholarly journals Sex-Specific Differences in Hemodialysis Prevalence and Practices and the Male-to-Female Mortality Rate: The Dialysis Outcomes and Practice Patterns Study (DOPPS)

PLoS Medicine ◽  
2014 ◽  
Vol 11 (10) ◽  
pp. e1001750 ◽  
Author(s):  
Manfred Hecking ◽  
Brian A. Bieber ◽  
Jean Ethier ◽  
Alexandra Kautzky-Willer ◽  
Gere Sunder-Plassmann ◽  
...  
Keyword(s):  
Mortality Rate ◽  
Practice Patterns ◽  
Female Mortality ◽  
Dialysis Outcomes ◽  
Male To Female
Sign in / Sign up

Export Citation Format

Share Document